FLDM - Fluidigm receives Emergency Use Authorization from the FDA for saliva-based Advanta Dx SARS-CoV-2 RT-PCR assay for COVID-19 (Stock Price: 8.79) early morning news
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.